In vitro maturation of human immunodeficiency virus type 1 Gag virus-like particle
人类免疫缺陷病毒1型Gag病毒样颗粒的体外成熟
基本信息
- 批准号:11670309
- 负责人:
- 金额:$ 2.3万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1999
- 资助国家:日本
- 起止时间:1999 至 2000
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Human immunodeficiency virus (HIV) Gag proteins are assembled underneath the plasma membrane to form the budding virus particles. During or after budding, the particles undergo the process termed maturation in which Gag is cleaved by virion-containing HIV protease to yield the N-terminal matrix (MA), the central capsid (CA), the nucleocapsid (NC), the C-terminal p6 proteins. Concomitant with the processing, doughnut-like HIV particles (the immature form) are converted to particles containing condensed cores (the mature form). As the immature particles are non-infectious, the maturation process are essential for HIV infectivity. However, it is difficult to undestand nature of Gag processing in cell-based experiments as the process of virus particle budding and that of Gag processing are interlinked and neither process is not synchronized. To understand this process, we carried out the in vitro processing of immature HIV Gag virus-like particle (VLP) by exogenously added HIV protease. Fo … More llowing delipidization with Triton X-100, sequential processing of immature VLP was carried out in acidic or neutral buffers with different concentrations of salt and confirmed the optimum activity for HIV PR (mildly acidic pH and low salt concentration). Under all conditions tested, the MA/CA junction was cleaved faster than the CA/NC junction, an altered order of processing when compared with authentic processing. When the in vitro- processed VLP was analyzed on sucrose density gradients, most of MA, CA-p15 intermediate, and NC were detected as a highly multimeric form, equivalent to the unprocessed VLP.Reverse transcriptase, a processing product of the Pot region, was also found associated to the highly multimeric complex. In contrast, CA was found as a monomer dissociated from the multimeric CA-p15 following cleavage of the CA/NC junction. Electron microscopy revealed that the in vitro processing was accompanied by conversion of the doughnut-like particles to particles containing outer shells (which may correspond to a multimer of MA) and condensed cores (likely corresponding to a complex of NC and RNA). Chracteristic of most of the cores was the absence of core shells. These results imply that the processing order in VLP may be important for core shell formation but not outer shell or core formation. To examine whether in vitro processing of the immature particles leads to produce infectious particles, we initially explored a method by which the lipid bilayer of VLP was permeabilized without a loss of viral envelope protein.Immature pseudotype particles was prepared by co-transfection with HIV proviral DNA clone whose PR was inactive and env gene was replaced with the GFP gene and expression plasmid of vesicular stomatitis virus G protein. Following in vitro processing, the processed pseudotype particles were inoculated on 239T or HeLa cells. The level of GFP expression will clarify whether or not the in vitro-processed particles are capable to produce integration-competent replication complexes. Less
人类免疫缺陷病毒(HIV)Gag蛋白在质膜下组装,形成萌芽中的病毒颗粒。在发芽过程中或发芽后,颗粒经历了一个称为成熟的过程,在这个过程中,GAG被含有病毒粒子的HIV蛋白酶切割,产生N端基质(MA)、中央衣壳(CA)、核衣壳(NC)和C端p6蛋白。随着加工的进行,甜甜圈状的艾滋病毒颗粒(未成熟的形式)被转化为含有凝聚核心的颗粒(成熟的形式)。由于未成熟的颗粒是非传染性的,成熟过程对艾滋病毒的传染性是必不可少的。然而,在基于细胞的实验中,很难理解GAG处理的本质,因为病毒颗粒发芽和GAG处理的过程是相互关联的,并且两个过程都不同步。为了了解这一过程,我们通过外源添加HIV蛋白酶对未成熟的HIV Gag病毒样颗粒(VLP)进行了体外加工。FO…用Triton X-100对未成熟的VLP进行了更缓慢的脱脂,并在不同盐浓度的酸性或中性缓冲液中进行了顺序处理,确定了对HIV PR的最佳活性(中等酸性和低盐浓度)。在所有测试的条件下,MA/CA结的切割速度快于CA/NC结,与真正的加工相比,加工顺序发生了变化。当对体外处理的VLP进行蔗糖密度梯度分析时,大多数MA、CA-p15中间体和NC被检测到为高度多聚体,相当于未处理的VLP。Pot区的加工产物反向转录酶也与高度多聚体复合体相关。相反,在CA/NC连接被切割后,CA被发现是从多聚体CA-p15解离的单体。电子显微镜显示,在体外处理过程中,甜甜圈状颗粒转化为含有外壳(可能对应于MA的多聚体)和凝聚核(可能对应于NC和RNA的络合物)的颗粒。大多数岩心的特征是没有核壳。这些结果表明,VLP中的加工顺序可能对核壳的形成很重要,但对外壳或核的形成并不重要。为了验证体外处理VLP的未成熟颗粒是否会产生感染性颗粒,我们初步探索了一种在不损失病毒包膜蛋白的情况下渗透VLP脂双层的方法,将PR失活的HIV前病毒DNA克隆与水泡性口炎病毒G蛋白的GFP基因和表达载体共转染成未成熟的伪型颗粒。体外处理后,将处理后的伪型颗粒接种到239T或HeLa细胞上。GFP的表达水平将阐明体外处理的颗粒是否能够产生整合能力强的复制复合体。较少
项目成果
期刊论文数量(20)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Y.Morikawa, D.Hockley, M.Nermut, and I.Jones: "Roles of matrix, p2, and N-terminal myristoylation in human immunodeficiency virus type 1 Gag assembly"J.Virol.. 74. 16-23 (2000)
Y.Morikawa、D.Hockley、M.Nermut 和 I.Jones:“人类免疫缺陷病毒 1 型 Gag 组装中基质、p2 和 N 末端肉豆蔻酰化的作用”J.Virol.. 74. 16-23 (2000
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
S.Harada,E.Haneda,Y.Morikawa,S.Funayama, et al.: "Casein kinase II (CK-II)-mediated stimulation of HIV-1 reverse transcriptase activity and characterization of selective inhibitors in vitro"Biol.Pharm.Bull.. 22. 1122-1126 (1999)
S.Harada、E.Haneda、Y.Morikawa、S.Funayama 等人:“酪蛋白激酶 II (CK-II) 介导的 HIV-1 逆转录酶活性刺激和体外选择性抑制剂的表征”Biol.Pharm
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Y.Morikawa,D.Hockley M.Nermut,and I.Jones: "Roles of matrix, p2, and N-terminal myristoylation in human immunodeficiency virus type 1 Gag assembly"J.Virol.. 74. 16-23 (2000)
Y.Morikawa、D.Hockley M.Nermut 和 I.Jones:“人类免疫缺陷病毒 1 型 Gag 组装中基质、p2 和 N 末端肉豆蔻酰化的作用”J.Virol.. 74. 16-23 (2000)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Y.Morikawa, and S.Sakuragi: "HIV particle assembly (in Japanese)"Igaku-no-ayumi. 189. 997-1001 (1999)
Y.Morikawa 和 S.Sakuragi:“HIV 粒子组装(日语)”Igaku-no-ayumi。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
S.Harada, E.Haneda, T.Maekawa, Y.Morikawa, S.Funayama, and K.Ohtsuki: "Casein kinase II (CK-II)-mediated stimulation of HIV-1 reverse transcriptase activity and characterization of selective inhibitors in vitro"Biol.Pharm.Bull.. 22. 1122-1126 (1999)
S.Harada、E.Haneda、T.Maekawa、Y.Morikawa、S.Funayama 和 K.Ohtsuki:“酪蛋白激酶 II (CK-II) 介导的 HIV-1 逆转录酶活性刺激以及选择性抑制剂的表征
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MORIKAWA Yuko其他文献
The Experiences of People with Early Onset Dementia at Work
早发性痴呆症患者的工作经历
- DOI:
- 发表时间:
2019 - 期刊:
- 影响因子:0
- 作者:
IKEUCHI Satomi;OMOTE Shizuko;TANAKA Kouji;OKAMOTO Rie;MORIKAWA Yuko;IRITANI Osamu - 通讯作者:
IRITANI Osamu
MORIKAWA Yuko的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MORIKAWA Yuko', 18)}}的其他基金
The determinants of health literacy and social capital among workers and those effects on health
工人健康素养和社会资本的决定因素及其对健康的影响
- 批准号:
18K10093 - 财政年份:2018
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular modification for MHC class I and II antigen presentation
MHC I 类和 II 类抗原呈递的分子修饰
- 批准号:
24659211 - 财政年份:2012
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Live-cell imaging of HIV replication component trafficking and assembly
HIV复制成分运输和组装的活细胞成像
- 批准号:
22390091 - 财政年份:2010
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
A study on the relation of shift work on hormonal change and diseases of prostate
轮班工作对激素变化与前列腺疾病关系的研究
- 批准号:
22590557 - 财政年份:2010
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Follow-up study on adjustment to night and shift work ; a year follow up for sleep, fatigue and biomarkers
夜间、轮班工作调整的跟踪研究;
- 批准号:
19590603 - 财政年份:2007
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of host factors responsible for virus paraticle production and screening of its inhibitors through yeast CytoTrap system
通过酵母 CytoTrap 系统鉴定负责病毒颗粒产生的宿主因子并筛选其抑制剂
- 批准号:
18390144 - 财政年份:2006
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Effect of night and shift work on glucose tolerance-circadian rhythm of glucose tolerance and insulin resistance
夜班和倒班工作对糖耐量的影响——糖耐量和胰岛素抵抗的昼夜节律
- 批准号:
16590520 - 财政年份:2004
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of Host Factors for Virus Particle Release Based on Yeast Genetics
基于酵母遗传学的病毒颗粒释放宿主因素的鉴定
- 批准号:
15390152 - 财政年份:2003
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Effects of Night Work on the Immune Function
夜间工作对免疫功能的影响
- 批准号:
14570362 - 财政年份:2002
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Non-infectious virus particle budding by yeast spheroplasts
酵母原生质球出芽的非感染性病毒颗粒
- 批准号:
13670307 - 财政年份:2001
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
TMEM30A介导的磷脂酰丝氨酸外翻促进毛细胞-SGN突触发育成熟的机制研究
- 批准号:82371172
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
神经胶质成熟因子-β对肝星状细胞活化和肝纤维化的影响及其机制研究
- 批准号:30800508
- 批准年份:2008
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Determining the molecular mechanisms of HIV-1 maturation
确定 HIV-1 成熟的分子机制
- 批准号:
10750083 - 财政年份:2023
- 资助金额:
$ 2.3万 - 项目类别:
Effects of HIV- and ARV-Induced Oxidative Stress on Neuroglial Cells
HIV 和 ARV 诱导的氧化应激对神经胶质细胞的影响
- 批准号:
8633340 - 财政年份:2013
- 资助金额:
$ 2.3万 - 项目类别:
Effects of HIV- and ARV-Induced Oxidative Stress on Neuroglial Cells
HIV 和 ARV 诱导的氧化应激对神经胶质细胞的影响
- 批准号:
8542181 - 财政年份:2013
- 资助金额:
$ 2.3万 - 项目类别:
Chimeric adenoviruses for an improved HIV vaccine
用于改进艾滋病毒疫苗的嵌合腺病毒
- 批准号:
8255434 - 财政年份:2011
- 资助金额:
$ 2.3万 - 项目类别:
Chimeric adenoviruses for an improved HIV vaccine
用于改进艾滋病毒疫苗的嵌合腺病毒
- 批准号:
8446338 - 财政年份:2011
- 资助金额:
$ 2.3万 - 项目类别:
Chimeric adenoviruses for an improved HIV vaccine
用于改进艾滋病毒疫苗的嵌合腺病毒
- 批准号:
8070197 - 财政年份:2011
- 资助金额:
$ 2.3万 - 项目类别:
Chimeric adenoviruses for an improved HIV vaccine
用于改进艾滋病毒疫苗的嵌合腺病毒
- 批准号:
8617207 - 财政年份:2011
- 资助金额:
$ 2.3万 - 项目类别:
Examining Trans-infection of HIV in Isolated Dendritic Cells
检查分离树突状细胞中 HIV 的转染情况
- 批准号:
7599039 - 财政年份:2008
- 资助金额:
$ 2.3万 - 项目类别:
Mechanisms of MHC-II antigen processing of HIV in macrophages and dendritic cells
巨噬细胞和树突状细胞中 HIV MHC-II 抗原加工机制
- 批准号:
7337009 - 财政年份:2007
- 资助金额:
$ 2.3万 - 项目类别: